Ali Behbahani - Jun 15, 2022 Form 4 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Director, 10%+ Owner
Signature
/s/ Louis Citron, attorney-in-fact
Stock symbol
GLUE
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
4
Date filed
6/16/2022, 05:29 PM
Previous filing
Jun 14, 2022
Next filing
Jun 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLUE Stock Option (Right to Buy) Award $0 +15K $0.00 15K Jun 15, 2022 Common Stock 15K $7.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become excercisable in full upon the earlier to occur of (i) June 15, 2023 or (ii) the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service at such time.